From Surf Wiki (app.surf) — the open knowledge base

Daniel L. Simmons

Daniel L. Simmons is a professor of chemistry and former director of the Cancer Research Center at Brigham Young University (BYU). He was the discoverer of the COX-2 enzyme that is the target of celecoxib (Celebrex) and other COX-2 inhibitors. He and BYU felt that Pfizer had not properly credited or paid them for Simmons work in this development and brought a suit against Pfizer.

Rendering article…

Content sourced from manual.

This content may have been generated or modified by AI, and may be sourced from third parties. CloudSurf Software LLC makes no warranties as to its accuracy, completeness, or reliability, and accepts no liability for it. Always verify important information against primary sources.

Report